This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Abiomed Past Earnings Performance

Past criteria checks 4/6

Key information

5.2%

Earnings growth rate

4.7%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate12.3%
Return on equity17.3%
Net Margin24.8%
Last Earnings Update30 Sep 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Abiomed makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:AIO Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 221,074267452175
30 Jun 221,056218438171
31 Mar 221,032137423164
31 Dec 211,003133413153
30 Sep 21974149392143
30 Jun 21935154368131
31 Mar 21848226333119
31 Dec 20813200318114
30 Sep 20803208317107
30 Jun 20798159324101
31 Mar 2084120334299
31 Dec 1984124533999
30 Sep 1982022133498
30 Jun 1979725832696
31 Mar 1976925932294
31 Dec 1873722231689
30 Sep 1869019030282
30 Jun 1864116528379
31 Mar 1859411226374
31 Dec 175449024768
30 Sep 175059223567
30 Jun 174757722866
31 Mar 174455221865
31 Dec 164154820364
30 Sep 163864319161
30 Jun 163594217854
31 Mar 163303816449
31 Dec 1530312615244

Quality Earnings: AIO has a large one-off gain of $61.8M impacting its September 30 2022 financial results.

Growing Profit Margin: AIO's current net profit margins (24.8%) are higher than last year (15.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AIO's earnings have grown by 5.2% per year over the past 5 years.

Accelerating Growth: AIO's earnings growth over the past year (78.9%) exceeds its 5-year average (5.2% per year).

Earnings vs Industry: AIO earnings growth over the past year (78.9%) exceeded the Medical Equipment industry -37.2%.


Return on Equity

High ROE: AIO's Return on Equity (17.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.